LEP and breast cancer: Moreover, when co-injecting MCF7 breast cancer cells and transfected MSCs with leptin shRNA into SCID/beige mice, a reduction in leptin levels in MSCs occurs, finally causing a decrease in the number of metastatic lesions and in the MCF7 tumor volume in the mouse livers and lungs [158].